Magic mushroom science: could a blood test predict who it helps?
NCT ID NCT07164755
Summary
This study is analyzing blood samples from a previous trial to understand how psilocybin (a compound in certain mushrooms) might work for treatment-resistant depression. Researchers are measuring inflammation markers in the blood to see if a person's level of inflammation before treatment, or how it changes afterward, is linked to how much their depression improves. The goal is to learn more about how psilocybin works and potentially find clues to better match future patients with this therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King's College London Institute of Psychiatry, Psychology and Neuroscience
London, SE5 8AF, United Kingdom
Conditions
Explore the condition pages connected to this study.